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Despite extensive investigation  over the  past  decade,  the  mechanism  of specific 
target cell recognition and lysis by cytolytic T  lymphocytes (CTL) 1 remains obscure 
(for recent reviews, see ref.  1 and  2).  One promising approach to this problem has 
been the derivation of antisera  (or monoclonal antibodies)  that  have the ability to 
block cytolytic activity in the absence of complement. Although early studies using 
heterologous  antisera  met  with  mixed  results  (reviewed  in  ref.  3),  more  recent 
experiments with monoclonal antibodies have clearly defined at least two antigenic 
structures on CTL, which may be implicated in antigen recognition and/or cytolysis. 
Thus, monoclonal antibodies directed against the Lyt-2/3 molecular complex (4-10) 
or the LFA-1 surface antigen  (1 I,  12)  have been shown to block CTL activity in a 
variety of experimental systems. 
A  major  difficulty in  the  interpretation  of antibody blocking experiments  is  to 
ascertain  whether or not  the  structure(s)  recognized by  the  antibodies  is  actually 
implicated  in  the  functional  activity  being  measured.  In  this  context,  the  recent 
development of T  cell cloning technology (reviewed in ref.  13) has provided homo- 
geneous  populations  of CTL  that  can  be  subjected  to  somatic  cell  genetic  and 
biochemical analysis. Using antibody selection methods on a mutagenized CTL clone, 
Dialnyas et al.  (14)  were able to isolate a  Lyt-2-/3- variant which failed to express 
cytolytic activity, thus  suggesting  a  crucial  role for this  molecular complex in  the 
cytolytic mechanism. In apparent contrast to these findings, Giorgi et al. (15) obtained 
a spontaneous Lyt-2- variant of another CTL clone that retained cytolytic function. 
Conflicting results regarding the possible role of Lyt-2/3 molecules in cytolysis were 
also obtained in proteolytic digestion experiments. Whereas Fan  and  Bonavida  (9) 
concluded that there was a good correlation between loss of Lyt-2 antigenic determi- 
nants  and  loss  of CTL  activity  in  trypsinized  populations  of alloimmune  cells, 
Ledbetter et  al.  (10)  found  that  CTL activity was  considerably more  resistant  to 
trypsin than Lyt-2/3 antigens. 
In view of these apparently contradictory findings, we reinvestigated the role of the 
1Abbreviations used in this paper:  CTL, cytolytic T  lymphocyte; DME, Dulbecco's modified Eagle's 
medium; MLC, mixed leukocyte  culture; MLTC, mixed leukocyte/tumor cell culture; MSV, murine 
sarcoma virus-murine  leukemia virus. 
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Lyt-2/3  molecular  complex  in  T  cell-mediated  cytolysis  at  the  clonal  level.  In 
agreement  with  an  earlier  report  (8),  we  show  that  there  is  considerable  clonal 
heterogeneity in the ability of CTL to be blocked by monoclonal anti-Lyt-2 or anti- 
Lyt-3  antibodies.  Furthermore,  by  using  quantitative  trypsinization  methods  on 
selected  CTL  clones,  we  demonstrate  that  this  heterogeneity  of  inhibition  most 
probably reflects a  true  heterogeneity  in  the  requirement  for  Lyt-2/3  molecules  in 
antigen  recognition by these  cells. Based on  these  findings, a  novel function  of the 
Lyt-2/3 molecules in the stabilization of CTL antigen receptors will be proposed. 
Materials  and  Methods 
Derivation and Maintenance of CTL Clones.  Clone L3 was derived by limiting dilution from a 
long-term in vitro primed C57BL/6  anti-DBA/2 secondary mixed leukocyte culture (MLC) 
population as described elsewhere (16). Clone C10 was derived by limiting dilution from an in 
vivo primed C57BL/6 anti-DBA/2 secondary MLC population (17). 
C57BL/6 CTL clones against murine sarcoma virus-murine leukemia virus (MSV)-associated 
antigens were derived by micromanipulating single cells from in vivo primed secondary mixed 
leukocyte/tumor cell (MLTC) cultures. These clones were selected for cross-reactive cytolytic 
activity by  simultaneous  testing  against  MSV-infected  syngeneic  (MBL-2)  and  uninfected 
allogeneic (P-815)  tumor target cells. 
All clones were maintained by weekly restimulation of 1-5 X  104 cloned cells with 5 ×  106 
irradiated (2,000  rad) antigenic (allogeneic or syngeneic virus-infected) spleen cells in 2 ml of 
Dulbecco's  modified  Eagle's  medium  (DME)  supplemented  with  2%  fetal  bovine  serum, 
additional amino acids (17),  5 X  10  _5 M  2-mercaptoethanol, and 2-3%  (vol/vol) supernatant 
from phorbol myristic acetate-stimulated EL-4 leukemia cells as a source of interleukin 2 (18). 
Cell recovery after 5-7 d ranged from 0.2 to 1 ×  106 viable cloned cells. 
MonoclonalAntibodies.  Monoclonal rat IgG antibodies against nonpolymorphic determinants 
of Lyt-2 (53-6.7)  and Lyt-3 (53-5.1)  antigens were kindly provided by Dr. J. Ledbetter, Stanford 
University, CA. Monoclonal rat IgM antibodies against Thy-l.2 (AT83) were kindly provided 
by Dr F. Fitch, University of Chicago, Chicago, IL. Monoclonal mouse IgG antibodies against 
H-2K  b (B8-24)  were kindly provided by Dr G. KShler, Basel Institute for Immunology, Basel, 
Switzerland. A monoclonal rat antibody that inhibits T cell-mediated cytolysis (H35-89.9) was 
kindly provided by  Dr.  M.  Pierres  and  Dr.  P.  Golstein, Centre  d'Immunologie INSERM- 
CNRS, Marseille, France. The properties of all of these reagents have been described in detail 
elsewhere (7, 12, 19, 20). 
Trypsin Treatment of CTL Clones.  Cloned cells were washed twice in serum-free DME and 
resuspended at a concentration of I ×  106 cells/ml in the presence of various concentrations of 
trypsin (type XI, DPCC treated, Sigma Chemical Co., St. Louis, MO). After 30 min at 37°C, 
15% (vol/vol) bovine serum was added to block trypsin activity, and the cells were washed two 
additional  times  at  4°C.  Treated  or  control  cells were  then  analyzed  for  surface  marker 
expression and cytolytic activity as described below. 
Flow Microfluorometry.  Expression of surface Lyt-2, Lyt-3, Thy-l.2,  H-2K  b,  and  H35.89.9 
antigens on  CTL  clones was  quantitated  by  flow  mierofluorometry as  described in  detail 
elsewhere (21). Briefly, aliquots of 3 x  105 cells were incubated sequentially at 4°C with optimal 
concentrations (i-5 p.g) of monoclonal antibodies followed by fluoresceinated rabbit anti-rat or 
rabbit anti-mouse Ig (20-50 #g). Samples were passed on a  FACS II flow cytometer (Becton, 
Dickinson & Co., Sunnyvale, CA) gated to exclude nonviable cells. Between 5,000  and 20,000 
cells were accumulated for each histogram. 
Inhibition of Cytolytic Activity.  Cytolytic activity of cloned CTL was assessed by mixing various 
numbers of cells with 2 ×  103 S~Cr-labeled target cells (either P-815, of DBA/2 origin, or MSV- 
infected MBL-2, of C57BL/6 origin) in 200/~1 final volume in round-bottomed microtiter wells. 
After 3 h  at 37°C, plates were centrifuged and supernatants were removed and counted in a 
well-type  scintillation counter. Percent specific 51Cr release was calculated as described elsewhere 
(17). In the trypsin treatment experiments, a minor modification of this protocol was used (22). 
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37°C.  EDTA  was  then added  to  a  final concentration of  10 mM  and the plates left  for an 
additional 90 rain, at which time aXCr release was assessed. In this way,  the effective duration 
of the  assay  was  restricted  to  30  rain  (22).  No  re-expression  of Lyt-2  or  Lyt-3  antigens  on 
trypsinized clones was observed within this 30-min period  (data not shown). 
For the antibody inhibition studies, a  fixed number (usually 4  ×  103) of cloned CTL were 
preincubated with various concentrations of monoclonal antibodies in a volume of 100 #1 for 20 
rain at 20°C.  Then 2 X  103 mCr-labeled target cells (100 #1) were added for an additional 3 h, 
and mCr release was assessed. To normalize results in certain experiments, results are expressed 
as  percent  inhibition according  to  the  formula:  percent  inhibition of cytolysis  --  1 -  ([mCr 
release with inhibitot]/[mCr release without inhibitor]) x  100. 
Results 
Differential Effect of Anti-Lyt-2/3 Antibodies on CTL Clones C10 and L3.  We previously 
demonstrated a marked heterogeneity in the inhibitory effect of monoclonal anti-Lyt- 
2 antibodies on cytolysis by CTL populations and short-term clones (8). To investigate 
this phenomenon  in  greater detail,  representative  clones  of the  inhibited  (L3)  and 
uninhibited  (Cl0)  phenotype were established as long-term cell lines and tested for 
their susceptibility to inhibition  by monoclonal antibodies directed against Lyt-2 or 
Lyt-3.  As shown  in  Fig.  1,  clone  L3 was  inhibited  in  a  dose-dependent  fashion  by 
either anti-Lyt-2 or anti-Lyt-3 antibodies, with 50% inhibition  at doses of 10ng per 
well. On the other hand, clone C10 was not significantly inhibited by doses of either 
antibody as high as 5 #g per well. This dramatic dissociation between the two clones 
was not a property of the particular antibodies used because IgM or IgG monoclonal 
antibodies directed against either polymorphic or nonpolymorphic determinants on 
the Lyt-2 molecule behaved in a similar fashion  (data not shown). 
Expression of Lyt-2/3 Antigens  by clones L3 and CIO.  One trivial explanation for the 
observed failure of clone C10  to be inhibited  by anti-Lyt-2/3  antibodies  would  be 
lack  of the  corresponding  antigenic  structures.  This  possibility  was  excluded  by 
quantitative flow microfluorometry. As shown in Fig. 2, clones L3 and C 10 appeared 
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Fro.  I.  Differential inhibitory effect of monoclonal anti-Lyt-2/3 antibodies on CTL clones L3 and 
C 10. Cloned CTL were incubated with the indicated amount ofanti-Lyt-2 or anti-Lyt-3 monoclonal 
antibody and subsequently tested for cytotoxicity against mCr-labeled P-815  (DBA/2) target cells 
at a  2:1  ratio.  For purposes of comparison, data are expressed as percent  inhibition relative to 
control lysis in the absence of inhibitor (59% and 69% for L3 and C 10, respectively). 1714  FUNCTIONAL ANALYSIS OF  Lyt-2/3  MOLECULES 
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FIG.  2.  Quantitative expression of Lyt-2 antigens on CTL clones.  Aliquots of 3 X  105 cells  from 
CTL clones L3 and el0 were incubated with monoclonal rat anti-Lyt-2 antibodies (2 #g in 100 ~1), 
followed by fluoresceinated rabbit anti-rat immunoglobulin. Samples were run on an FACS II flow 
cytometer  gated  to  accumulate  20,000  viable  cells.  Each  fluorescence  histogram  (expressed  in 
arbitrary linear units) is compared with a control histogram obtained with the fluorescent conjugate 
alone. Primary (0/1) and in vivo primed secondary (1/1) C57BL/6 anti-DBA/2 MLC populations 
were included as an internal control. 
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FIG. 3.  Failure of a "LFA-l-like" monoclonal antibody to dissociate between CTL clones L3 and 
el0.  Cloned  CTL  were preincubated with  various dilutions of monoclonal antibodies directed 
against  either  Lyt-2  or  H35-89.9  (a  molecular  complex  similar  to  LFA-1;  see  ref.  12)  and 
subsequently tested  for  cytotoxicity  against  P-815  target  cells  at  a  2:1  ratio.  For  purposes of 
comparison, data  are  expressed as  percent  inhibition relative  to  control  lysis  in  the  absence of 
antibody (34% and 67% for L3 and C10, respectively). 
to express comparable amounts of Lyt-2 molecules. Similar results were obtained for 
Lyt-3 (data not shown). 
Failure  of Another  Cytolysz~-inhibiting Antibody  to  Dissociate  between L3  and  CIO.  To 
determine whether  the  dissociation  of inhibition  of cytolytic activity of clones  el0 
and  L3 was unique  for antibodies  directed  against  the  Lyt-2/3 molecular complex, 
we also investigated the effect of an  independent  monoclonal  antibody  (H35-89.9) 
which has been reported to inhibit CTL activity (12).  H35-89.9 immunoprecipitates 
two  membrane polypeptides  of apparent  180,000  and  94,000  tool  wt  and  is  thus H.  R.  MACDONALD,  A.  L.  GLASEBROOK,  AND J.-C.  CEROq"FINI  1715 
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FIG. 4.  Trypsin sensitivity of Lyt-2 antigenic determinants on clones L3 and C10.  Aliquots of 2 
X  l0  s cells from CTL clones L3 and C10 were treated with the indicated concentrations of trypsin 
and analyzed for the expression of Lyt-2 antigens by flow microfluorometry (see Fig. 2). Fluorescence 
intensity is expressed as a percentage of the untreated controls. 
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FIG.  5.  Differential  effect  of trypsin treatment  on  the  cytolytic  activity  of clones L3  and  C10. 
Aliquots of 2 X  106 ceils  from CTL clones L3 and C10 were treated with various concentrations of 
trypsin and assayed for cytolytic activity  against  P-815  target  cells  at  various effector/target cell 
ratios using a short-term (30 rain) modification of the 5]Cr release assay (22). 
unrelated to anti-Lyt-2/3, although similar to the anti-LFA-1 antibody described by 
Davignon  et  al.  (11).  When  tested  against  CTL  clones  L3  and  C10,  H35-89.9 
inhibited cytolytic activity to a comparable extent (Fig. 3). 
Effect of Trypsin  Treatment on Lyt-2/3 Expression and Cytolytic Activity  of Clones L3 and 
CIO.  The  extreme  trypsin  sensitivity  of the  Lyt-2/3  antigenic  complex  is  well 
documented (10,  23). It was therefore of interest to examine in parallel the effect of 
trypsin treatment on Lyt-2/3 expression and cytolytic activity of clones L3 and C 10. 
In agreement with previous studies of murine thymocytes by Ledbetter et al.  (10), 
moderate doses of trypsin (25-100 #g/ml for 30 rain) were sufficient to remove Lyt-2 
antigens from clones L3 and C 10 (Fig. 4). When these trypsin-treated cells were tested 
in parallel for their cytolytic activity using a  short-term  (30 rain)  ~lCr release assay 
(22), a striking dissociation was observed. Whereas clone L3 lost 90% and 99% of its 
cytolytic activity after treatment with 25 #g/ml and 50/xg/ml of trypsin, respectively, 1716  FUNCTIONAL  ANALYSIS  OF  I,yt-2/3  MOLECULES 
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FIG. 6.  Correlation between Lyt-2/3 expression and cytolytic activity in trypsin-treated L3 cells. 
Aliquots of CTL clone L3  (2 ×  106 cells) were exposed to the indicated concentrations of trypsin 
and divided into three aliquots. Two aliquots were stained with monoclonal anti-Lyt-2 or mono- 
clonal anti-Lyt-3 antibodies and analyzed by flow microfluorometry (cf., Fig. 2). The third aliquot 
was assayed for cytolytic activity against P-815  target cells at various effector/target cell ratios (cf. 
Fig.  5). Cytolytic activity was  converted to lyric units (17) and expressed as a  percentage of the 
mock-treated control.  Relative Lyt-2 or  Lyt-3  fluorescence  intensity was  likewise  expressed as a 
percentage of the control. 
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FIG.  7.  Differential blocking effect  of monoclonal  anti-Lyt-2  antibodies on  specific  and  cross- 
reactive lysis  mediated  by  a  C57BL/6  anti-MSV CTL  clone.  A  micromanipulated CTL  clone 
derived from a day-7 MLTC population was expanded and assayed for cytolytic activity against its 
specific target (MBL-2)  or against a third-party allogeneic target (P-815) in the presence or absence 
of various concentrations of monoclonal anti-Lyt-2 antibodies. For purposes of comparison, data are 
presented as percent inhibition relative to control lysis in the absence of antibody (31% and 81% 
against  MBL-2 and  P-815,  respectively,  at  an effector/target ratio of 5:1).  Similar  results were 
obtained with four other clones derived in the same experiment (not shown). 
clone el0  was resistant to treatment  with up to  100 #g/ml  (Fig.  5). With  lower doses 
of trypsin  (1-30 #g/ml),  clone  L3  lost  cytolytic  activity  in  a  dose-dependent  fashion 
that paralleled loss of the Lyt-3 antigenic determinant  (Fig.  6).  In this dose range, no 
significant effect of trypsin treatment  on the expression of other cell surface antigens, 
such as Thy-1,  H-2K b,  Lyt-2,  or H35-89.9  by clone L3,  could  be detected  (data  not 
shown). H.  R.  MACDONALD,  A.  L.  GLASEBROOK,  AND J.-C.  CEROTTINI  1717 
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FIG.  8.  Differential effect  of trypsin treatment on specific  and cross-reactive lysis mediated by a 
C57BL/6 anti-MSV CTL clone. The same clone as in Fig.  7 was treated with trypsin (100 #g/ml) 
and assayed for cytotoxicity against MBL-2 or P-815  target cells at various effector:target cell ratios 
using a  short-term SlCr-release  assay. Untreated cloned CTL were included as a  positive control. 
Similar results were obtained with a second clone (not shown). 
Effect  of Anti-Lyt-2 Antibodies and Trypsin  Treatment on Clones with Cross-Reactive Lytic 
Activity.  Results obtained with clones C10 and L3 indicated  a  clear dissociation in 
their apparent requirement for Lyt-2/3 molecules in the killing process. Furthermore, 
as shown elsewhere (8), this dissociation correlates in general with in vivo priming. To 
determine whether such a  dissociation could be observed in lytic activities mediated 
by a  single clone, we took advantage of the fact that  a  significant proportion of in 
vivo primed C57BL/6 anti-MSV clones lyse uninfected allogeneic (P-815) target cells 
(24,  25). When five such clones (isolated by micromanipulation) were tested for their 
ability to lyse specific (MBL-2) or cross-reactive (P-815) target cells in the presence or 
absence of various concentrations of anti-Lyt-2 antibodies, a marked dissociation was 
observed. As shown for a representative clone in Fig. 7, lysis of MBL-2 target cells was 
not  significantly inhibited  at  any antibody concentration  tested  (up  to  1 #g/well), 
whereas  lysis of P-815  target  cells was completely inhibited,  even at  low antibody 
doses (10 ng/well). Furthermore, when two of these clones were treated with  100 #g/ 
ml trypsin (a dose that removed 90% of the Lyt-2 antigenic determinants), only lysis 
of P-815  target  cells was affected  (Fig.  8).  Thus,  two independent  specificities of a 
single  CTL  clone  could  be  dissociated  either  by  antibody  blocking  or  by trypsin 
treatment. 
Discussion 
The experiments described in this communication provide direct evidence for clonal 
heterogeneity in the requirement  for Lyt-2/3 molecules in T  cell-mediated cytolysis. 
Whereas certain C57BL/6  anti-DBA/2  CTL clones  (such  as L3)  were inhibited  by 
low doses (10 ng) of monoclonal anti-Lyt-2 or anti-Lyt-3 antibodies, other clones (such 
as  C10)  were not  inhibited  by concentrations  as  high  as  5  #g.  Treatment  of these 
clones with doses of trypsin sufficient to cleave Lyt-2/3 antigenic determinants from 
the  cell  surface confirmed  this  apparent  dissociation  in  the  sense  that  "inhibited" 
clones  lost  cytolytic  activity,  whereas  "uninhibited"  clones  did  not.  Furthermore, 1718  FUNCTIONAL ANALYSIS OF  Lyt-2/3 MOLECULES 
cross-reactive C57BL/6  anti-MSV  CTL clones  were  derived  that  exhibited  an  in- 
hibited,  trypsin-sensitive  phenotype  when  tested  against  allogeneic  third-party  (P- 
815)  target cells and an uninhibited,  trypsin-resistant phenotype when tested against 
syngeneic  (MBL-2)  target  cell.  Taken  together,  these  data  lead  to  the  paradoxical 
conclusion that Lyt-2/3 molecules are essential for some CTL/target cell interactions 
but not for others. 
The implications of these findings for the functional role of Lyt-2/3 molecules on 
CTL warrant further discussion. In the first place, the ability of trypsin-treated CTL 
clones (which lack detectable Lyt-2/3 antigenic determinants) to effectively lyse target 
cells  argues  strongly  against  the  possibility  that  these  molecules  function  either  as 
antigen  receptors  or  as  an  essential  component  of the  lytic  machinery  on  CTL. 
Although  the  presence  of partially  degraded  Lyt-2/3  molecules  on  the  surface  of 
trypsin-treated  cells  cannot  be ruled  out,  the  observed correlation  between  trypsin 
resistance  and  resistance  to  inhibition  with  monoclonal  anti-Lyt-2/3  antibodies 
provides compelling evidence that such CTL do indeed recognize and destroy target 
cells in a manner which is functionally independent  of the Lyt-2/3 complex. 
The results obtained with the trypsin-sensitive CTL clones  (such as L3) should be 
interpreted  with caution.  Whereas  loss of cytolytic activity of these cells correlated 
quantitatively  with  loss  of Lyt-3  antigenic  determinants,  it  is  difficult  to  formally 
exclude  the  possibility  that  this  correlation  may  reflect  the  trypsin  sensitivity  of 
another protein that is unrelated to Lyt-2/3. Despite these limitations, however, the 
trypsin sensitivity data are consistent both with antibody blocking experiments (Fig. 
1)  and with  the  finding  that  Lyt-2-/3- variants of clone L3 fail to exhibit  specific 
cytolytic activity (14).  Taken together, these results lead to the conclusion that CTL 
vary clonally in  their functional  dependence  upon a  trypsin-sensitive structure  that 
cannot be dissociated from Lyt-2/3. 
Previous attempts to correlate Lyt-2/3 antigenic expression with cytolytic function 
at either the population  (9,  10) or clonal (14,  15) level have led to conflicting results. 
In view of our past  (8)  and  present  findings,  it  is  tempting to speculate  that  these 
observed experimental discrepancies could  have resulted  simply from heterogeneity 
in Lyt-2/3 requirements for killing in the particular CTL populations or clones under 
study.  Indeed,  the noncytolytic Lyt-2/3- variant CTL clone of Dialnyas et al.  (14) 
was derived  from the same parental  CTL clone  (L3)  that  was shown  to be trypsin 
sensitive and anti°Lyt-2 inhibitable  in the present study.  Similarly, the alloimmune 
spleen cell population  used as a  source of CTL in the study of Ledbetter et al.  (10) 
would be expected, on the basis of our results, to contain a  majority of CTL that are 
not  inhibited  by anti-Lyt-2 antibodies.  It  is  thus  not  surprising  that  these  authors 
found  cytolytic  activity  to  be  more  resistant  to  trypsin  treatment  than  Lyt-2/3 
expression.  Unfortunately,  the  parental  CTLL-2  line  corresponding  to  the  Lyt-2- 
variant CTL clone that  retained  cytolytic activity in  the study of Giorgi et al.  (15) 
was not  characterized  for inhibition  of function  by anti-Lyt-2 antibodies;  however, 
based on our results with C10 and other similar CTL clones, we would expect their 
original line to be uninhibited.  As for the experiments of Fan and Bonavida (9),  the 
high concentrations of trypsin used by these authors (1-5 mg/ml) make any compar- 
isons with the present study very difficult. 
No  apparent  qualitative  or quantitative  differences in  the  expression  of Lyt-2/3 
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study. Thus, clones L3 and C10 expressed comparable amounts of Lyt-2 and Lyt-3 
antigens as assessed by flow microfluorometry. Furthermore, when exposed to various 
doses of trypsin, Lyt-2 and Lyt-3 antigenic determinants were lost in a parallel fashion 
on clones L3 and C 10. Preliminary analysis ofimmunoprecipitated surface x25I-labeled 
Lyt-2/3  antigens  on  these  clones  by  sodium  dodecyl  sulfate  polyacrylamide  gel 
electrophoresis under reducing conditions indicates a  similar  pattern with a  major 
broad  band  of approximately  40,000  mol  wt  (26).  More  detailed  comparisons  of 
peptides immunoprecipitated from these and  other CTL clones  (using  two-dimen- 
sional gel electrophoresis) will be required to assess  possible structural microhetero- 
geneity in the expression of Lyt-2/3 antigens. 
Of particular  interest  in  the  present  study was  the  failure of another cytolysis- 
inhibiting monoclonal antibody (H35-89.9)  to differentially inhibit CTL clones L3 
and C10 that were heterogeneous with respect to anti-Lyt-2 inhibition. As described 
elsewhere (12), H35-89.9 reacts with two surface polypeptides of 94,000 and  180,000 
apparent mol wt on the surface of B and T  cells, and this antibody inhibits mitogen- 
induced T  (but not B) cell proliferation as well as T  cell-mediated cytolysis. Thus, in 
many  respects  the  determinant  recognized  by  H35-89.9  is  similar  to  the  LFA-1 
antigen  described  by  Davignon  et  al.  (11).  The  fact  that  clones  L3  and  C10,  in 
addition to a larger series of 50 micromanipulated C57BL/6 anti-DBA/2 CTL clones 
(A. L. Glasebrook and H. R. MacDonald, unpublished data), were uniformly inhibited 
by H35-89.9 in a  manner that was independent of their susceptibility to inhibition 
by anti-Lyt-2 antibodies argues strongly in favor of a  unique mechanism governing 
anti-Lyt-2 inhibition (vide infra). 
An important question arising from our data is whether the apparent requirement 
for  Lyt-2/3  molecules  on  certain  CTL  clones  (such  as  L3)  is  related  to  antigen 
recognition or to some aspect of the cytolytic process itself. On the one hand, direct 
evidence against  the  latter possibility comes from the observation  that  other CTL 
clones  (such  as  C10)  in  which  Lyt-2/3  molecules  have  been  either  blocked  (by 
antibodies)  or removed (by trypsin) are still able to mediate cytolysis. On the other 
hand, additional independent evidence in favor of an involvement of Lyt-2/3 mole- 
cules  in  antigen  recognition  is  provided  by  our  recent  demonstration  that  other 
functions of selected CTL clones, including antigen-dependent proliferation and the 
secretion of lymphokines such as interferon-  7 and macrophage-activating factor, can 
be inhibited by monoclonal anti-Lyt-2/3 antibodies in a manner that strictly parallels 
inhibition ofcytolysis (26). The fact that several (presumably independent) functional 
activities of  cloned CTL exhibit a similar dependence upon Lyt-2/3 molecules strongly 
suggests that a common initial pathway (most likely antigen recognition) is involved. 
How then can the differing inhibition phenotypes of CTL clones be reconciled with 
a consistent model for the role of the Lyt-2/3 molecular complex in T  cell-mediated 
antigen recognition? Given that Lyt-2/3 molecules do not constitute the CTL antigen 
receptor, one attractive hypothesis would be that these molecules somehow function 
to stabilize the interaction between the putative receptor and the appropriate anti- 
genie determinant(s) on the target cells. Irrespective of how this stabilization process 
might occur at the molecular level, one important corollary to this postulate would be 
that, as the number and/or affinity of  CTL antigen receptors increase, the requirement 
for Lyt-2/3 molecules to stabilize the binding would decrease. Thus, in an operational 
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be inversely proportional to either the number and/or affinity of its antigen receptors. 
It  is  instructive  to consider  the  trypsin  results  obtained  with  cross-reactive CTL 
clones  in  the  light  of  this  hypothesis.  Because  trypsin  treatment  eliminated  the 
allospecific lytic activity of these clones without  affecting their anti-MSV activity, it 
could  be  argued  that  these  cloned  CTL  have  two  antigen  receptors,  one  trypsin- 
sensitive (anti-allo) and the other trypsin-resistant (anti-MSV). Although this hypoth- 
esis cannot be formally disproved, it is nevertheless difficult to reconcile with the fact 
that both trypsin-sensitive and trypsin-resistant lytic activities were observed for other 
anti-allo  (Fig. 5)  and anti-MSV  (H. R. MacDonald, unpublished  data) CTL clones. 
Thus, we prefer to interpret our results in the context of a single receptor (altered self) 
model  (27)  in which  the cross-reactive CTL receptor has relatively high affinity for 
one antigen  (in this case MSV)  and low affinity for the other  (allo). As discussed in 
detail above, the dissociation oflytic specificities of these clones after trypsin treatment 
would result as a consequence of the fact that trypsin-sensitive Lyt-2/3 molecules are 
required  to stabilize low affinity receptor binding,  rather than  as a  consequence  of 
any direct effect of trypsin on the receptor itself. 
Finally, although our hypothesis cannot be experimentally tested in the absence of 
any molecular definition  of CTL antigen  receptors, it  is  nevertheless  interesting  to 
compare some aspects of anti-Lyt-2/3 inhibition at the clonal level with what might 
be predicted  by such  a  "receptor affinity" model.  First,  the  observed  inhibition  of 
lytic activity of CTL clones by monoclonal anti-Lyt-2 antibodies is very heterogeneous. 
In contradistinction  to the extreme situations  represented  by clones such as L3 and 
C 10 (this report), data obtained with a larger number of CTL clones (reference 8 and 
unpublished results) suggest that the degree of inhibition of lytic activity of individual 
clones  is  distributed  in  a  continuous  (rather  than  "all  or  none")  fashion.  Such  a 
continuous  distribution  would  be  consistent  with  the  concept  of a  wide  range  of 
receptor affinities. Second, the degree of inhibition of CTL by anti-Lyt-2 antibodies, 
measured either at the population or clonal level, is dramatically reduced when the 
CTL  have  been  derived  from  precursors  selected  by  in  vivo  priming  with  the 
appropriate antigens. Thus, CTL populations or clones obtained either from alloim- 
mune peritoneal  exudate  cells  (8)  or from restimulated  populations  of alloimmune 
spleen (this report) are much more difficult to inhibit with anti-Lyt-2 antibodies than 
CTL obtained in primary MLC. These differences in susceptibility to inhibition are 
not restricted to alloreactive CTL because most CTL clones recognizing H-2-restricted 
syngeneic antigens, such as MSV  (this report), are likewise resistant to inhibition  by 
monoclonal anti-Lyt-2 antibodies when derived from in vivo primed cell populations. 
If CTL responses, like antibody responses  (28),  select in  vivo for precursors of high 
affinity, it is reasonable to assume that such differences in affinity might be reflected 
in the clonal progeny of such cells maintained  in vitro. In such a  case, quantitative 
inhibition experiments of CTL clones with monoclonal anti-Lyt-2/3 antibodies, such 
as  those  described  in  this  report,  may prove to  be  a  useful  (and  unique)  tool  for 
making operational estimates of the relative affinity of CTL antigen receptors. 
Summary 
While it is well established that murine cytolytic T  lymphocytes (CTL) express the 
Lyt-2/3  molecular complex on  their surface,  conflicting results  have been  reported 
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was reinvestigated at the clonal level. Although different (H-2  b anti-H-2 d) CTL clones 
expressed comparable amounts of Lyt-2/3 molecules, as assessed by quantitative flow 
microfluorometry, the activity of some clones was inhibited  by low doses  (10 ng)  of 
monoclonal  anti-Lyt-2  or  anti-Lyt-3  antibodies  (in  the  absence  of complement), 
whereas other clones were not inhibited  by either antibody at doses as high as 5/~g. 
Treatment  of these clones with doses of trypsin sufficient to cleave Lyt-2/3 antigenic 
determinants  from the cell surface resulted in a  similar dissociation: clones that were 
inhibited  by  antibodies  lost  cytolytic  activity,  whereas  "uninhibited"  clones  were 
unaffected by trypsin treatment.  Moreover, the dissociation observed among different 
alloreactive clones could be demonstrated within selfoH-2-restricted (H-2 b anti-MSV) 
clones  exhibiting  cross-reactivity  with  normal  H-2  d  products.  The  lytic  activity  of 
these clones against  the relevant  syngeneic target  cells was unaffected by anti-Lyt-2 
antibodies or trypsin, whereas their cross-reactivity on H-2  d target cells was abolished 
by either treatment. 
These results  provide direct  evidence  for clonal  heterogeneity  in the requirement 
for Lyt-2/3 molecules in CTL-mediated lysis. It is proposed that the function of Lyt- 
2/3  molecules  is  to stabilize  the  interaction  between  CTL  receptors  and  the  corre- 
sponding antigens on the target cells and that the requirement  for such a stabilization 
is correlated with low number and/or affinity of CTL receptors. 
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